FIELD: medicine, pharmaceutics.
SUBSTANCE: present application describes substituted bicyclic beta-lactams of formula I: which are class A and class C β-lactamase inhibitors wherein X, R1 and R2 are specified in the application, as well as a method for producing them. The compounds of formula I and their pharmaceutically acceptable salts are applicable for preparing a pharmaceutical composition and for producing a drug. The declared compounds are applicable for treating bacterial infections, optionally in a combination with a β-lactam antibiotic. Particularly, the compounds may be used with such β-lactam antibiotics, as e.g. imipenem, piperacillin or ceftazidime to control microorganisms resistant to β -lactam antibiotics due to the presence of β-lactamases.
EFFECT: preparing the composition for treating bacterial infections.
28 cl, 117 ex, 3 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
1,6-DIAZABICYCLO [3,2,1] OCTANE-7-ONA DERIVATIVES AND USE THEREOF FOR TREATING BACTERIAL INFECTIONS | 2013 |
|
RU2614418C2 |
METHOD OF PRODUCING HETEROCYCLIC COMPOUNDS, INCLUDING TRANS-7-OXO-6-(SULPHOXY)-1,6-DIAZABICYCLO[3.2.1]OCTANE-2-CARBOXAMIDE AND ITS SALT | 2012 |
|
RU2769076C2 |
(2S,5R)-5-[(BENZYLOXY)AMINO]PIPERIDINE-2-CARBOXAMIDE | 2012 |
|
RU2610091C2 |
NOVEL BETA-LACTAMASE INHIBITOR AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2693898C2 |
NEW β-LACTAMASE INHIBITOR AND A METHOD OF ITS PRODUCTION | 2019 |
|
RU2800050C2 |
BETA-LACTAMASE INHIBITORS AND THEIR USE | 2018 |
|
RU2815314C2 |
BETA-LACTAMASE INHIBITORS AND APPLICATION THEREOF | 2018 |
|
RU2753401C2 |
CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND METHOD FOR PRODUCTION THEREOF | 2014 |
|
RU2695219C2 |
METHOD OF PRODUCING A DIAZABICYCLOOCTANE DERIVATIVE AND INTERMEDIATE THEREOF | 2014 |
|
RU2719480C2 |
CRYSTALLINE FORMS OF DIAZABICLOCTANE DERIVATIVE AND A METHOD OF THEIR PRODUCTION | 2014 |
|
RU2801220C2 |
Authors
Dates
2012-03-20—Published
2009-01-15—Filed